Livestock Animal Rehabilitation Services Market Size, Share, and Trends 2025 to 2034

The global livestock animal rehabilitation services market size is calculated at USD 211.65 million in 2025 and is forecasted to reach around USD 586.45 million by 2034, accelerating at a CAGR of 11.99% from 2025 to 2034. The North America market size surpassed USD 58.59 million in 2024 and is expanding at a CAGR of 12.17% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Last Updated : June 2025  |  Report Code : 6172  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Livestock Animal Rehabilitation Services Market 

5.1. COVID-19 Landscape: Livestock Animal Rehabilitation Services Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Livestock Animal Rehabilitation Services Market, By Animal Type

8.1. Livestock Animal Rehabilitation Services Market, by Animal Type

8.1.1. Cattle

8.1.1.1. Market Revenue and Forecast

8.1.2. Poultry

8.1.2.1. Market Revenue and Forecast

8.1.3. Others

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Livestock Animal Rehabilitation Services Market, By Therapy Type

9.1. Livestock Animal Rehabilitation Services Market, by Therapy Type

9.1.1. Therapeutic Exercises

9.1.1.1. Market Revenue and Forecast

9.1.2. Manual Therapy  

9.1.2.1. Market Revenue and Forecast

9.1.3. Hydrotherapy

9.1.3.1. Market Revenue and Forecast

9.1.4. Hot & Cold Therapies

9.1.4.1. Market Revenue and Forecast

9.1.5. Electro Therapies

9.1.5.1. Market Revenue and Forecast

9.1.6. Acupuncture

9.1.6.1. Market Revenue and Forecast

 

9.1.7. Shockwave Therapy

9.1.7.1. Market Revenue and Forecast

9.1.8. Other Therapies

9.1.8.1. Market Revenue and Forecast

Chapter 10. Global Livestock Animal Rehabilitation Services Market, By Indication 

10.1. Livestock Animal Rehabilitation Services Market, by Indication

10.1.1. Post-Surgery

10.1.1.1. Market Revenue and Forecast

10.1.2. Traumatic Injuries

10.1.2.1. Market Revenue and Forecast

10.1.3. Acute & Chronic Diseases

10.1.3.1. Market Revenue and Forecast

10.1.4. Developmental Abnormality

10.1.4.1. Market Revenue and Forecast

10.1.5. Other Indications

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Livestock Animal Rehabilitation Services Market, By End Use 

11.1. Livestock Animal Rehabilitation Services Market, by End Use

11.1.1. Veterinary Rehab Centers & Hospitals

11.1.1.1. Market Revenue and Forecast

11.1.2. Rescue & Shelter Homes

11.1.2.1. Market Revenue and Forecast

11.1.3. Others

11.1.3.1. Market Revenue and Forecast

Chapter 12. Global Livestock Animal Rehabilitation Services Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Animal Type

12.1.2. Market Revenue and Forecast, by Therapy Type

12.1.3. Market Revenue and Forecast, by Indication

12.1.4. Market Revenue and Forecast, by End Use

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Animal Type

12.1.5.2. Market Revenue and Forecast, by Therapy Type

12.1.5.3. Market Revenue and Forecast, by Indication

12.1.5.4. Market Revenue and Forecast, by End Use

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Animal Type

12.1.6.2. Market Revenue and Forecast, by Therapy Type

12.1.6.3. Market Revenue and Forecast, by Indication

12.1.6.4. Market Revenue and Forecast, by End Use

12.2. Europe

12.2.1. Market Revenue and Forecast, by Animal Type

12.2.2. Market Revenue and Forecast, by Therapy Type

12.2.3. Market Revenue and Forecast, by Indication

12.2.4. Market Revenue and Forecast, by End Use

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Animal Type

12.2.5.2. Market Revenue and Forecast, by Therapy Type

12.2.5.3. Market Revenue and Forecast, by Indication

12.2.5.4. Market Revenue and Forecast, by End Use

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Animal Type

12.2.6.2. Market Revenue and Forecast, by Therapy Type

12.2.6.3. Market Revenue and Forecast, by Indication

12.2.6.4. Market Revenue and Forecast, by End Use

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Animal Type

12.2.7.2. Market Revenue and Forecast, by Therapy Type

12.2.7.3. Market Revenue and Forecast, by Indication

12.2.7.4. Market Revenue and Forecast, by End Use

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Animal Type

12.2.8.2. Market Revenue and Forecast, by Therapy Type

12.2.8.3. Market Revenue and Forecast, by Indication

12.2.8.4. Market Revenue and Forecast, by End Use

12.3. APAC

12.3.1. Market Revenue and Forecast, by Animal Type

12.3.2. Market Revenue and Forecast, by Therapy Type

12.3.3. Market Revenue and Forecast, by Indication

12.3.4. Market Revenue and Forecast, by End Use

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Animal Type

12.3.5.2. Market Revenue and Forecast, by Therapy Type

12.3.5.3. Market Revenue and Forecast, by Indication

12.3.5.4. Market Revenue and Forecast, by End Use

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Animal Type

12.3.6.2. Market Revenue and Forecast, by Therapy Type

12.3.6.3. Market Revenue and Forecast, by Indication

12.3.6.4. Market Revenue and Forecast, by End Use

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Animal Type

12.3.7.2. Market Revenue and Forecast, by Therapy Type

12.3.7.3. Market Revenue and Forecast, by Indication

12.3.7.4. Market Revenue and Forecast, by End Use

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Animal Type

12.3.8.2. Market Revenue and Forecast, by Therapy Type

12.3.8.3. Market Revenue and Forecast, by Indication

12.3.8.4. Market Revenue and Forecast, by End Use

12.4. MEA

12.4.1. Market Revenue and Forecast, by Animal Type

12.4.2. Market Revenue and Forecast, by Therapy Type

12.4.3. Market Revenue and Forecast, by Indication

12.4.4. Market Revenue and Forecast, by End Use

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Animal Type

12.4.5.2. Market Revenue and Forecast, by Therapy Type

12.4.5.3. Market Revenue and Forecast, by Indication

12.4.5.4. Market Revenue and Forecast, by End Use

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Animal Type

12.4.6.2. Market Revenue and Forecast, by Therapy Type

12.4.6.3. Market Revenue and Forecast, by Indication

12.4.6.4. Market Revenue and Forecast, by End Use

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Animal Type

12.4.7.2. Market Revenue and Forecast, by Therapy Type

12.4.7.3. Market Revenue and Forecast, by Indication

12.4.7.4. Market Revenue and Forecast, by End Use

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Animal Type

12.4.8.2. Market Revenue and Forecast, by Therapy Type

12.4.8.3. Market Revenue and Forecast, by Indication

12.4.8.4. Market Revenue and Forecast, by End Use

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Animal Type

12.5.2. Market Revenue and Forecast, by Therapy Type

12.5.3. Market Revenue and Forecast, by Indication

12.5.4. Market Revenue and Forecast, by End Use

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Animal Type

12.5.5.2. Market Revenue and Forecast, by Therapy Type

12.5.5.3. Market Revenue and Forecast, by Indication

12.5.5.4. Market Revenue and Forecast, by End Use

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Animal Type

12.5.6.2. Market Revenue and Forecast, by Therapy Type

12.5.6.3. Market Revenue and Forecast, by Indication

12.5.6.4. Market Revenue and Forecast, by End Use

Chapter 13. Company Profiles

13.1. Greenside Veterinary Practice

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Chaseview Farm Animal Service

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. St Boniface Veterinary Centre

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Deepwood Veterinary Clinic

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Desert Forest Animal Hospital

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. REC Vet Physio

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Animal Health & Rehab Center

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Pedernales Veterinary Center

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Ladson Veterinary Hospital

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Tabernacle Animal Hospital

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global livestock animal rehabilitation services market is expected to increase from USD 188.99 million in 2024 to USD 586.45 million by 2034.

The livestock animal rehabilitation services market is expected to grow at a compound annual growth rate (CAGR) of around 11.99% from 2025 to 2034.

The major players major in the livestock animal rehabilitation services market include Greenside Veterinary Practice, Chaseview Farm Animal Service, St Boniface Veterinary Centre, Deepwood Veterinary Clinic, Desert Forest Animal Hospital, REC Vet Physio, Animal Health & Rehab Center, Pedernales Veterinary Center, Ladson Veterinary Hospital, and Tabernacle Animal Hospital.

The driving factors of the livestock animal rehabilitation services market are the farmers and livestock owners are increasingly recognizing the advantages of rehabilitation therapies, resulting in greater uptake of these services, especially for issues such as lameness and recovery after surgery.

North America region will lead the global livestock animal rehabilitation services market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client